title: Azelnidipine and amlodipine: a comparison of their effects and safety in a randomized double-blinded clinical trial in Chinese essential hypertensive patients.
authors.affiliation: Beijing Tongren Hospital, Capital Medical University, Beijing, China. Xiulizhao@medmail.com.cn
authors.forename: Xiuli
authors.initials: X
authors.lastname: Zhao
authors.forename: Feng
authors.initials: F
authors.lastname: Wu
authors.forename: Sanqing
authors.initials: S
authors.lastname: Jia
authors.forename: Peng
authors.initials: P
authors.lastname: Qu
authors.forename: Huimin
authors.initials: H
authors.lastname: Li
authors.forename: Xingshan
authors.initials: X
authors.lastname: Zhao
authors.forename: Bo
authors.initials: B
authors.lastname: Cao
authors.forename: Yiping
authors.initials: Y
authors.lastname: Lin
authors.forename: Mulan
authors.initials: M
authors.lastname: Wang
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D017311:Amlodipine / Q000008:administration & dosage* / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001383:Azetidinecarboxylic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018660:Blood Pressure Monitoring, Ambulatory; D002681:China; D004095:Dihydropyridines / Q000008:administration & dosage* / Q000627:therapeutic use; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D004095:Dihydropyridines; D017311:Amlodipine; D001383:Azetidinecarboxylic Acid; C061679:azelnidipine